Joon Seok Choi

Joon Seok Choi

Auto-generated profile, based on publicly available information

Joon Seok Choi

Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YKYong Un Kang
Yong Un Kang
HKHa Yeon Kim
Ha Yeon Kim
JCJoon Seok Choi
Joon Seok Choi
CKChang Seong Kim
Chang Seong Kim
EBEun Hui Bae
Eun Hui Bae
SKSoo Wan Kim
Soo Wan Kim
This study was aimed to examine the prevalence of metabolic syndrome (MS) and chronic kidney disease (CKD), and the association between MS and its components with CKD in Korea. We excluded diabetes to appreciate the real impact of MS and performed a cross-sectional study using the general health screening data of 10,253,085 (48.86±13.83 years, men 56.18%) participants (age, ≥20 years) from the Korean National Health Screening 2011. CKD was defined as dipstick proteinuria ≥1 or an estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m2. The prevalence of CKD was 6.15% (men, 5.37%; women, 7.15%). Further, 22.25% study population had MS (abdominal obesity, 27.98%; hypertriglyceridemia, 30.09%; low high-density cholesterol levels, 19.74%; high blood pressure, 43.45%; and high fasting glucose levels, 30.44%). Multivariate-adjusted analysis indicated that proteinuria risk increased in participants with MS (odds ratio [OR] 1.884, 95% confidence interval [CI] 1.867–1.902, P<0.001). The presence of MS was associated with eGFR<60 mL/min/1.73 m2 (OR 1.364, 95% CI 1.355–1.373, P<0.001). MS individual components were also associated with an increased CKD risk. The strength of association between MS and the development of CKD increase as the number of components increased from 1 to 5. In sub-analysis by men and women, MS and its each components were a significant determinant for CKD. MS and its individual components can predict the risk of prevalent CKD for men and women.

1 January 2013 in International Heart Journal
Verified
Journal Article
Open access
PDF file
CKChang Seong Kim
Chang Seong Kim
MKMin Jee Kim
Min Jee Kim
YKYong Un Kang
Yong Un Kang
JCJoon Seok Choi
Joon Seok Choi
EBEun Hui Bae
Eun Hui Bae
SKSoo Wan Kim
Soo Wan Kim
The clinical course and medical treatment of patients with congestive heart failure (CHF) complicating acute myocardial infarction (AMI) are not well established, especially in patients with concomitant renal dysfunction. We performed a retrospective analysis of the prospective Korean Acute Myocardial Infarction Registry to assess the medical treatments and clinical outcomes of patients with CHF (Killip classes II or III) complicated by AMI, in the presence or absence of renal dysfunction. Of 13,498 patients with AMI, 2769 (20.5%) had CHF on admission. Compared to CHF patients with preserved renal function, in-hospital mortality and major adverse cardiac events were increased both at 1 month and at 1 year after discharge in patients with renal dysfunction (1154; 41.7%). Postdischarge use of aspirin, betablockers, calcium channel blockers, angiotensin-converting enzyme inhibitors, or angiotensin II receptor blockers and statins significantly reduced the 1-year mortality rate for CHF patients with renal dysfunction; such reduction was not observed for those without renal dysfunction, except in the case of aspirin. Patients with CHF complicating AMI, which is accompanied by renal dysfunction, are at higher risk for adverse cardiovascular outcomes than patients without renal dysfunction. However, they receive fewer medications proven to reduce mortality rates.

1 January 2013 in Infection & Chemotherapy
Verified
Journal Article
Open access
JKJi Hyoun Kang
Ji Hyoun Kang
MKMin Jee Kim
Min Jee Kim
YKYong Un Kang
Yong Un Kang
CKChang Seong Kim
Chang Seong Kim
JCJoon Seok Choi
Joon Seok Choi
SKSoo Wan Kim
Soo Wan Kim
We report a case of Serratia marcescens peritonitis in a 45-year-old man with insulin-dependent diabetes mellitus undergoing continuous ambulatory peritoneal dialysis (CAPD). The patient presented with abdominal pain and cloudy dialysate. Empiric antibiotic therapy was initiated intraperitoneally with cefazolin and ceftazidime for 5 days. Cultures of the dialysate revealed S. marcescens, and the treatment was subsequently changed to gentamicin and ceftazidime. Oral ciprofloxacin was also added. The patient's abdominal pain and the dialysate white blood cell (WBC) count, however, did not improve. The indwelling CAPD catheter was therefore removed. This is an unusual case report in the Korean literature of S. marcescens peritonitis in a patient receiving CAPD.

1 January 2021 in Case Reports in Pediatrics
Verified
Journal Article
Open access
PDF file
ZBZachary Barbara
Zachary Barbara
SESavannah P. Ellenwood
Savannah P. Ellenwood
ELEmily D. Loe
Emily D. Loe
JCJoon Choi
Joon Choi
KRKathleen Ryan
Kathleen Ryan
NJNancy Joseph
Nancy Joseph
Kawasaki disease is a medium vessel vasculitis with a multisystem presentation affecting 9–20 per 100,000 children under 5 years of age in the United States. Salmonella coinfection has not been previously described. We present a 12‐month‐old vaccinated male with Kawasaki disease in the setting of Salmonella bacteremia. Initial intervention for the Kawasaki disease with IVIG was ineffective, prompting adjunctive therapy with anakinra, with eventual full recovery. Concurrent Kawasaki disease and bacteremia may confound diagnosis and necessitate nontraditional treatment approaches.